待处理
入排:排除
图源:待检查
Corrigendum to "Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study" [Eur J Cancer 213 (December) (2024) 115078].
Arun A Azad, Karim Fizazi, Nobuaki Matsubara, Fred Saad, Ugo De Giorgi, Jae Young Joung, Peter C C Fong, Robert J Jones, Stefanie Zschäbitz, Jan Oldenburg, Neal D Shore, Curtis Dunshee, Joan Carles, Andre P Fay, Xun Lin, Liza DeAnnuntis, Nicola Di Santo, Michael A Zielinski, Neeraj Agarwal
Eur J Cancer 232 116106
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板